Leveraging HIV-Specific CAR T Cells and Rapamycin Treatment in “Kick-and-Kill” HIV Cure ApproachesNishad S. Maggirwar(University of California, Irvine), Matthew D. Marsden(University of California, Los Angeles)bioRxiv (Cold Spring Harbor Laboratory)January 15, 202610.64898/2026.01.15.699756Cited by 0SaveCiteExport RISWatch citationsRelated PapersIn vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication|PLoS Pathogens|2017|94Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal|Virology|2023|3